Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P4HB | P07237 | 6/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 5/20 | 1.00 |
| ▸ | EPHX2 | P34913 | 5/20 | 1.00 |
| ▸ | GAA | P10253 | 4/20 | 1.00 |
| ▸ | POLB | P06746 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | CA12 | O43570 | 3/20 | 1.00 |
| ▸ | CA2 | P00918 | 3/20 | 1.00 |
| ▸ | CA4 | P22748 | 3/20 | 1.00 |
| ▸ | CA7 | P43166 | 3/20 | 1.00 |
| ▸ | ALPL | P05186 | 2/20 | 1.00 |
| ▸ | ALPI | P09923 | 2/20 | 1.00 |
| ▸ | SLCO2B1 | O94956 | 2/20 | 1.00 |
| ▸ | MAOA | P21397 | 2/20 | 1.00 |
| ▸ | XDH | P47989 | 2/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 1/20 | 1.00 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 1.00 |
| ▸ | KDM1A | O60341 | 1/20 | 1.00 |
| ▸ | HMGB1 | P09429 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isoquercetin SCHEMBL23249 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL19490596 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL19212904 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL20150699 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL9916971 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL5312085 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL12566342 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL21244358 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL22495101 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL20292455 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1994923-A2 | Cosmetic and dermatological compositions for dry skin | Henkel AG & Co. KGaA (DE) | 2008-11-26 | — | — | EP | claimed |
| EP-1790330-A2 | Cosmetic and dermatological compositions containing oligopeptides and apple extract | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-05-30 | — | — | EP | claimed |
| EP-1634576-A1 | DNA repair enzymes and oligopeptides containing cosmetic and dermatological compositions | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-03-15 | — | — | EP | claimed |
| US-20040234466-A1 | Beta-glucuronidase inhibitors for use in deodorants and antiperspirants | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2004-11-25 | — | — | US | claimed |
| EP-1441691-A2 | BETA-GLUCURONIDASE INHIBITORS FOR USE IN DEODORANTS AND ANTIPERSPIRANTS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-08-04 | — | — | EP | claimed |
| EP-1430879-A2 | Arylsulfatase inhibitors in deodorants and antiperspirants | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-06-23 | — | — | EP | claimed |
| EP-1430933-A2 | Cosmetic and pharmaceutical compositions comprising steroid sulfatase inhibitors and their use for the reduction of hair loss | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-06-23 | — | — | EP | claimed |
| EP-1428520-A2 | Lipase inhibitors in deodorants and antiperspirants | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-06-16 | — | — | EP | claimed |
| EP-1393518-A2 | ARYLSULFATASE-INHIBITORS IN DEODORANTS AND ANTIPERSPIRANTS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-03-03 | — | — | EP | claimed |
| WO-2003039505-A2 | ss-GLUCURONIDASE INHIBITORS FOR USE IN DEODORANTS AND ANTIPERSPIRANTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-05-15 | — | — | WO | claimed |
| WO-2001099376-A2 | ARYLSULFATASE-INHIBITORS IN DEODORANTS AND ANTIPERSPIRANTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-12-27 | — | — | WO | claimed |
| US-11234918-B2 | Methods for botanical and/or algae extraction | BASF CORPORATION (US) | 2022-02-01 | — | — | US | disclosed |
| US-10981084-B2 | Use of coconut water as extraction solvent | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2021-04-20 | — | — | US | disclosed |
| CN-105838758-B | Water-soluble phenolic derivatives for cosmetic and therapeutic applications on the skin | 利布莱根公司 | 2020-03-06 | — | — | CN | disclosed |
| US-20190336884-A1 | USE OF COCONUT WATER AS EXTRACTION SOLVENT | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2019-11-07 | — | — | US | disclosed |
| EP-1430882-A2 | Combinations of antioxidants containing 6,7-disubstituted 2,2-dialkylchromanes or -chromenes | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-06-23 | — | — | EP | disclosed |
| EP-1430879-A2 | Arylsulfatase inhibitors in deodorants and antiperspirants | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-06-23 | — | — | EP | disclosed |
| EP-1428520-A2 | Lipase inhibitors in deodorants and antiperspirants | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-06-16 | — | — | EP | disclosed |
| EP-1393518-A2 | ARYLSULFATASE-INHIBITORS IN DEODORANTS AND ANTIPERSPIRANTS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-03-03 | — | — | EP | disclosed |
| WO-2001099376-A2 | ARYLSULFATASE-INHIBITORS IN DEODORANTS AND ANTIPERSPIRANTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11234918-B2 | Methods for botanical and/or algae extraction | ALG1, ALG8, CUTA | P4HB 3427/4885KDM4E 4367/4885AKR1B1 2466/4885 |
| US-20040234466-A1 | Beta-glucuronidase inhibitors for use in deodorants and antiperspirants | GUSB, PON1, IDUA | P4HB 537/4885KDM4E 3145/4885AKR1B1 847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.